Dehydroevodiamine hydrochloride

N/A

Report date: 2022/01/24 17:45:25
NME

Base Information

Drug NameDehydroevodiamine hydrochloride
Drug Alias Name盐酸去氢吴茱萸碱DHEDJES-9501
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionBeta amyloid A4 protein inhibitorsCholinesterase inhibitors
TargetsCholinesteraseBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of SeoulJeil Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of SeoulJeil Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A